Literature DB >> 24243538

Hyperexcitable C nociceptors in fibromyalgia.

Jordi Serra1, Antonio Collado, Romà Solà, Francesca Antonelli, Xavier Torres, Monika Salgueiro, Cristina Quiles, Hugh Bostock.   

Abstract

OBJECTIVE: To test the hypothesis that peripheral C nociceptor function may be abnormal in fibromyalgia and that C nociceptor dysfunction may contribute to the symptoms reported by these patients.
METHODS: Microneurography was used to record C nociceptors of 30 female patients meeting criteria for fibromyalgia and compared with recordings from 17 female patients with small-fiber neuropathy and 9 female controls.
RESULTS: We obtained stable recordings of 186 C nociceptors in the fibromyalgia group, 114 from small-fiber neuropathy patients, and 66 from controls. The mechanosensitive nociceptors in the fibromyalgia patients behaved normally, but the silent nociceptors in 76.6% of fibromyalgia patients exhibited abnormalities. Spontaneous activity was detected in 31% of silent nociceptors in fibromyalgia, 34% in small-fiber neuropathy, and 2.2% in controls. Sensitization to mechanical stimulation was found in 24.2% of silent nociceptors in fibromyalgia, 22.7% in small-fiber neuropathy, and 3.7% in controls. Abnormally high slowing of conduction velocity when first stimulated at 0.25Hz was more common in fibromyalgia.
INTERPRETATION: We show for the first time that the majority of fibromyalgia patients have abnormal C nociceptors. Many silent nociceptors exhibit hyperexcitability resembling that in small-fiber neuropathy, but high activity-dependent slowing of conduction velocity is more common in fibromyalgia patients, and may constitute a distinguishing feature. We infer that abnormal peripheral C nociceptor ongoing activity and increased mechanical sensitivity could contribute to the pain and tenderness suffered by patients with fibromyalgia.
© 2014 Child Neurology Society/American Neurological Association.

Entities:  

Mesh:

Year:  2014        PMID: 24243538     DOI: 10.1002/ana.24065

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  70 in total

1.  Neuronally produced versican V2 renders C-fiber nociceptors IB4 -positive.

Authors:  Oliver Bogen; Olaf Bender; Jana Löwe; Wolfgang Blenau; Beatrice Thevis; Wolfgang Schröder; Richard U Margolis; Jon D Levine; Ferdinand Hucho
Journal:  J Neurochem       Date:  2015-04-27       Impact factor: 5.372

Review 2.  [Fibromyalgia syndrome: A disease of the small nerve fibers?].

Authors:  N Üçeyler; C Sommer
Journal:  Z Rheumatol       Date:  2015-08       Impact factor: 1.372

3.  C-fiber recovery cycle supernormality depends on ion concentration and ion channel permeability.

Authors:  Jenny Tigerholm; Marcus E Petersson; Otilia Obreja; Esther Eberhardt; Barbara Namer; Christian Weidner; Angelika Lampert; Richard W Carr; Martin Schmelz; Erik Fransén
Journal:  Biophys J       Date:  2015-03-10       Impact factor: 4.033

Review 4.  Fibromyalgia and small fiber neuropathy: the plot thickens!

Authors:  Manuel Martínez-Lavín
Journal:  Clin Rheumatol       Date:  2018-09-20       Impact factor: 2.980

5.  Diagnostic value of blood tests for occult causes of initially idiopathic small-fiber polyneuropathy.

Authors:  Magdalena Lang; Roi Treister; Anne Louise Oaklander
Journal:  J Neurol       Date:  2016-10-11       Impact factor: 4.849

Review 6.  Assessment of Chronic Pain: Domains, Methods, and Mechanisms.

Authors:  Roger B Fillingim; John D Loeser; Ralf Baron; Robert R Edwards
Journal:  J Pain       Date:  2016-09       Impact factor: 5.820

7.  The somatosensory link in fibromyalgia: functional connectivity of the primary somatosensory cortex is altered by sustained pain and is associated with clinical/autonomic dysfunction.

Authors:  Robert R Edwards; Vitaly Napadow; Jieun Kim; Marco L Loggia; Christine M Cahalan; Richard E Harris; Florian Beissner; Ronald G Garcia; Hyungjun Kim; Ajay D Wasan
Journal:  Arthritis Rheumatol       Date:  2015-05       Impact factor: 10.995

Review 8.  [Etiology and pathophysiology of fibromyalgia syndrome : Updated guidelines 2017, overview of systematic review articles and overview of studies on small fiber neuropathy in FMS subgroups].

Authors:  N Üçeyler; M Burgmer; E Friedel; W Greiner; F Petzke; M Sarholz; M Schiltenwolf; A Winkelmann; C Sommer; W Häuser
Journal:  Schmerz       Date:  2017-06       Impact factor: 1.107

9.  End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain.

Authors:  Ann T Farrell; Julie Panepinto; C Patrick Carroll; Deepika S Darbari; Ankit A Desai; Allison A King; Robert J Adams; Tabitha D Barber; Amanda M Brandow; Michael R DeBaun; Manus J Donahue; Kalpna Gupta; Jane S Hankins; Michelle Kameka; Fenella J Kirkham; Harvey Luksenburg; Shirley Miller; Patricia Ann Oneal; David C Rees; Rosanna Setse; Vivien A Sheehan; John Strouse; Cheryl L Stucky; Ellen M Werner; John C Wood; William T Zempsky
Journal:  Blood Adv       Date:  2019-12-10

Review 10.  Neurogenic inflammation in fibromyalgia.

Authors:  Geoffrey Littlejohn; Emma Guymer
Journal:  Semin Immunopathol       Date:  2018-03-19       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.